Your session is about to expire
← Back to Search
Sodium Citrate for Long COVID Syndrome
Study Summary
This trial is testing the use of a nasal spray containing sodium citrate to help improve the sense of smell in people who have lost it after having COVID-19. The researchers want to find out if
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current number of individuals being recruited for participation in this clinical study?
"Indeed, the details on clinicaltrials.gov indicate that this trial is presently seeking individuals to participate. The study was initially published on December 1st, 2023 and was most recently updated on January 10th, 2024. A total of 60 patients are being sought for enrollment at a single site."
Are there any ongoing opportunities for patients to participate in this clinical trial at the moment?
"Indeed, according to the information on clinicaltrials.gov, this study is currently in the process of recruiting participants. The trial was initially posted on December 1st, 2023 and recently updated on January 10th, 2024. The research team aims to enroll a total of 60 patients at one designated site."
Has the Food and Drug Administration granted approval for the use of Sodium Citrate?
"Based on the categorization of this trial as Phase 2, our team at Power rates the safety profile of Sodium Citrate as a 2. While there is existing data supporting its safety, there is currently no evidence to support its efficacy in this context."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger